CLINICAL_TRIALS
research
· 2015-03-12
Clinical Trial Update: Pharmacokinetics of Dexmedetomidine in Morbid Obesity [Phase 4]
Summary
Phase 4 clinical trial update evaluating the pharmacokinetics of dexmedetomidine in individuals with obesity.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Guangzhou General Hospital of Guangzhou Military Command | Conditions: Obesity | Phase 4 | Status: UNKNOWN